nodes	percent_of_prediction	percent_of_DWPC	metapath
Moclobemide—CYP2D6—breast cancer	0.234	1	CbGaD
Moclobemide—CYP1A2—Anastrozole—breast cancer	0.0575	0.128	CbGbCtD
Moclobemide—CYP1A2—Toremifene—breast cancer	0.0526	0.117	CbGbCtD
Moclobemide—CYP2C9—Anastrozole—breast cancer	0.0518	0.115	CbGbCtD
Moclobemide—CYP2C19—Lapatinib—breast cancer	0.0416	0.0927	CbGbCtD
Moclobemide—CYP2C9—Idarubicin—breast cancer	0.0393	0.0875	CbGbCtD
Moclobemide—CYP2D6—Idarubicin—breast cancer	0.0359	0.08	CbGbCtD
Moclobemide—CYP2C9—Capecitabine—breast cancer	0.0215	0.0479	CbGbCtD
Moclobemide—CYP2C19—Tamoxifen—breast cancer	0.0208	0.0464	CbGbCtD
Moclobemide—CYP1A2—Tamoxifen—breast cancer	0.0192	0.0428	CbGbCtD
Moclobemide—CYP2D6—Vinorelbine—breast cancer	0.0175	0.0391	CbGbCtD
Moclobemide—CYP2C9—Tamoxifen—breast cancer	0.0173	0.0386	CbGbCtD
Moclobemide—CYP2D6—Tamoxifen—breast cancer	0.0158	0.0353	CbGbCtD
Moclobemide—CYP1A2—Fluorouracil—breast cancer	0.0142	0.0315	CbGbCtD
Moclobemide—CYP2C9—Paclitaxel—breast cancer	0.0135	0.03	CbGbCtD
Moclobemide—CYP2C9—Fluorouracil—breast cancer	0.0128	0.0284	CbGbCtD
Moclobemide—CYP2D6—Vinblastine—breast cancer	0.0108	0.0241	CbGbCtD
Moclobemide—CYP2D6—Doxorubicin—breast cancer	0.00664	0.0148	CbGbCtD
Moclobemide—Minaprine—ACHE—breast cancer	0.001	0.182	CrCbGaD
Moclobemide—Bezafibrate—SLCO1B1—breast cancer	0.000932	0.169	CrCbGaD
Moclobemide—Procainamide—DNMT1—breast cancer	0.00078	0.141	CrCbGaD
Moclobemide—MAOB—nipple—breast cancer	0.000647	0.0663	CbGeAlD
Moclobemide—MAOA—nipple—breast cancer	0.000552	0.0566	CbGeAlD
Moclobemide—MAOB—embryo—breast cancer	0.000534	0.0547	CbGeAlD
Moclobemide—CYP2C9—mammary gland—breast cancer	0.000528	0.0542	CbGeAlD
Moclobemide—Procainamide—SCN10A—breast cancer	0.000484	0.0876	CrCbGaD
Moclobemide—Procainamide—ACHE—breast cancer	0.000461	0.0835	CrCbGaD
Moclobemide—CYP1A2—nipple—breast cancer	0.00046	0.0472	CbGeAlD
Moclobemide—MAOA—embryo—breast cancer	0.000455	0.0467	CbGeAlD
Moclobemide—MAOB—endometrium—breast cancer	0.00039	0.04	CbGeAlD
Moclobemide—MAOB—uterus—breast cancer	0.00036	0.0369	CbGeAlD
Moclobemide—MAOB—pituitary gland—breast cancer	0.000353	0.0362	CbGeAlD
Moclobemide—MAOB—adipose tissue—breast cancer	0.000352	0.0361	CbGeAlD
Moclobemide—MAOA—endometrium—breast cancer	0.000333	0.0342	CbGeAlD
Moclobemide—Minaprine—CYP2D6—breast cancer	0.000324	0.0587	CrCbGaD
Moclobemide—MAOB—female reproductive system—breast cancer	0.000323	0.0332	CbGeAlD
Moclobemide—Bezafibrate—CYP1A1—breast cancer	0.000318	0.0575	CrCbGaD
Moclobemide—MAOB—adrenal gland—breast cancer	0.000316	0.0324	CbGeAlD
Moclobemide—MAOA—uterus—breast cancer	0.000307	0.0315	CbGeAlD
Moclobemide—MAOA—pituitary gland—breast cancer	0.000301	0.0309	CbGeAlD
Moclobemide—MAOA—adipose tissue—breast cancer	0.0003	0.0308	CbGeAlD
Moclobemide—MAOB—female gonad—breast cancer	0.000294	0.0302	CbGeAlD
Moclobemide—MAOA—female reproductive system—breast cancer	0.000276	0.0283	CbGeAlD
Moclobemide—MAOB—endocrine gland—breast cancer	0.000274	0.0281	CbGeAlD
Moclobemide—Procainamide—BCHE—breast cancer	0.000271	0.0491	CrCbGaD
Moclobemide—MAOA—adrenal gland—breast cancer	0.000269	0.0276	CbGeAlD
Moclobemide—MAOA—female gonad—breast cancer	0.000251	0.0258	CbGeAlD
Moclobemide—CYP2C19—endocrine gland—breast cancer	0.000239	0.0245	CbGeAlD
Moclobemide—MAOA—endocrine gland—breast cancer	0.000234	0.024	CbGeAlD
Moclobemide—CYP2C9—female reproductive system—breast cancer	0.000219	0.0224	CbGeAlD
Moclobemide—Haloperidol—CYP1A1—breast cancer	0.000206	0.0373	CrCbGaD
Moclobemide—Bezafibrate—CYP3A4—breast cancer	0.000203	0.0367	CrCbGaD
Moclobemide—CYP1A2—endocrine gland—breast cancer	0.000195	0.02	CbGeAlD
Moclobemide—MAOB—lymph node—breast cancer	0.000189	0.0194	CbGeAlD
Moclobemide—CYP2C9—endocrine gland—breast cancer	0.000185	0.019	CbGeAlD
Moclobemide—CYP2D6—female reproductive system—breast cancer	0.000164	0.0168	CbGeAlD
Moclobemide—MAOA—lymph node—breast cancer	0.000161	0.0166	CbGeAlD
Moclobemide—Haloperidol—CYP2D6—breast cancer	0.000153	0.0277	CrCbGaD
Moclobemide—CYP2D6—female gonad—breast cancer	0.000149	0.0153	CbGeAlD
Moclobemide—Procainamide—CYP2D6—breast cancer	0.000149	0.0269	CrCbGaD
Moclobemide—CYP2D6—endocrine gland—breast cancer	0.000139	0.0142	CbGeAlD
Moclobemide—Haloperidol—CYP3A4—breast cancer	0.000132	0.0238	CrCbGaD
Moclobemide—Haloperidol—ABCB1—breast cancer	0.000109	0.0198	CrCbGaD
Moclobemide—Somnolence—Paclitaxel—breast cancer	9.97e-05	0.000496	CcSEcCtD
Moclobemide—Palpitations—Capecitabine—breast cancer	9.97e-05	0.000496	CcSEcCtD
Moclobemide—Chest pain—Docetaxel—breast cancer	9.92e-05	0.000493	CcSEcCtD
Moclobemide—Myalgia—Docetaxel—breast cancer	9.92e-05	0.000493	CcSEcCtD
Moclobemide—Loss of consciousness—Capecitabine—breast cancer	9.91e-05	0.000493	CcSEcCtD
Moclobemide—Nausea—Vinorelbine—breast cancer	9.9e-05	0.000493	CcSEcCtD
Moclobemide—Dyspepsia—Paclitaxel—breast cancer	9.87e-05	0.000491	CcSEcCtD
Moclobemide—Asthenia—Mitoxantrone—breast cancer	9.87e-05	0.000491	CcSEcCtD
Moclobemide—Asthenia—Irinotecan—breast cancer	9.87e-05	0.000491	CcSEcCtD
Moclobemide—Stomatitis—Epirubicin—breast cancer	9.8e-05	0.000487	CcSEcCtD
Moclobemide—Conjunctivitis—Epirubicin—breast cancer	9.77e-05	0.000486	CcSEcCtD
Moclobemide—Dysuria—Doxorubicin—breast cancer	9.76e-05	0.000485	CcSEcCtD
Moclobemide—Decreased appetite—Paclitaxel—breast cancer	9.75e-05	0.000485	CcSEcCtD
Moclobemide—Hypertension—Capecitabine—breast cancer	9.74e-05	0.000484	CcSEcCtD
Moclobemide—Dry mouth—Docetaxel—breast cancer	9.7e-05	0.000482	CcSEcCtD
Moclobemide—Fatigue—Paclitaxel—breast cancer	9.67e-05	0.000481	CcSEcCtD
Moclobemide—Sweating—Epirubicin—breast cancer	9.64e-05	0.000479	CcSEcCtD
Moclobemide—Asthenia—Gemcitabine—breast cancer	9.61e-05	0.000478	CcSEcCtD
Moclobemide—Chest pain—Capecitabine—breast cancer	9.6e-05	0.000478	CcSEcCtD
Moclobemide—Myalgia—Capecitabine—breast cancer	9.6e-05	0.000478	CcSEcCtD
Moclobemide—Constipation—Paclitaxel—breast cancer	9.59e-05	0.000477	CcSEcCtD
Moclobemide—Confusional state—Docetaxel—breast cancer	9.58e-05	0.000477	CcSEcCtD
Moclobemide—Anxiety—Capecitabine—breast cancer	9.57e-05	0.000476	CcSEcCtD
Moclobemide—Discomfort—Capecitabine—breast cancer	9.49e-05	0.000472	CcSEcCtD
Moclobemide—Pruritus—Gemcitabine—breast cancer	9.48e-05	0.000471	CcSEcCtD
Moclobemide—Nausea—Thiotepa—breast cancer	9.46e-05	0.00047	CcSEcCtD
Moclobemide—Diarrhoea—Irinotecan—breast cancer	9.41e-05	0.000468	CcSEcCtD
Moclobemide—Diarrhoea—Mitoxantrone—breast cancer	9.41e-05	0.000468	CcSEcCtD
Moclobemide—Dry mouth—Capecitabine—breast cancer	9.39e-05	0.000467	CcSEcCtD
Moclobemide—Shock—Docetaxel—breast cancer	9.35e-05	0.000465	CcSEcCtD
Moclobemide—Pruritus—Fluorouracil—breast cancer	9.32e-05	0.000463	CcSEcCtD
Moclobemide—Drowsiness—Doxorubicin—breast cancer	9.3e-05	0.000463	CcSEcCtD
Moclobemide—Visual impairment—Methotrexate—breast cancer	9.29e-05	0.000462	CcSEcCtD
Moclobemide—Confusional state—Capecitabine—breast cancer	9.28e-05	0.000462	CcSEcCtD
Moclobemide—Tachycardia—Docetaxel—breast cancer	9.28e-05	0.000461	CcSEcCtD
Moclobemide—Feeling abnormal—Paclitaxel—breast cancer	9.24e-05	0.00046	CcSEcCtD
Moclobemide—Bradycardia—Epirubicin—breast cancer	9.19e-05	0.000457	CcSEcCtD
Moclobemide—Gastrointestinal pain—Paclitaxel—breast cancer	9.17e-05	0.000456	CcSEcCtD
Moclobemide—Diarrhoea—Gemcitabine—breast cancer	9.17e-05	0.000456	CcSEcCtD
Moclobemide—Dizziness—Irinotecan—breast cancer	9.09e-05	0.000452	CcSEcCtD
Moclobemide—Stomatitis—Doxorubicin—breast cancer	9.07e-05	0.000451	CcSEcCtD
Moclobemide—Shock—Capecitabine—breast cancer	9.05e-05	0.00045	CcSEcCtD
Moclobemide—Conjunctivitis—Doxorubicin—breast cancer	9.04e-05	0.00045	CcSEcCtD
Moclobemide—Diarrhoea—Fluorouracil—breast cancer	9.01e-05	0.000448	CcSEcCtD
Moclobemide—Tinnitus—Methotrexate—breast cancer	8.99e-05	0.000447	CcSEcCtD
Moclobemide—Tachycardia—Capecitabine—breast cancer	8.98e-05	0.000447	CcSEcCtD
Moclobemide—Sweating—Doxorubicin—breast cancer	8.92e-05	0.000444	CcSEcCtD
Moclobemide—Urticaria—Paclitaxel—breast cancer	8.91e-05	0.000443	CcSEcCtD
Moclobemide—Hyperhidrosis—Capecitabine—breast cancer	8.9e-05	0.000443	CcSEcCtD
Moclobemide—Hypotension—Docetaxel—breast cancer	8.88e-05	0.000442	CcSEcCtD
Moclobemide—Abdominal pain—Paclitaxel—breast cancer	8.87e-05	0.000441	CcSEcCtD
Moclobemide—Vomiting—Irinotecan—breast cancer	8.74e-05	0.000435	CcSEcCtD
Moclobemide—Vomiting—Mitoxantrone—breast cancer	8.74e-05	0.000435	CcSEcCtD
Moclobemide—Dizziness—Fluorouracil—breast cancer	8.71e-05	0.000433	CcSEcCtD
Moclobemide—Visual impairment—Epirubicin—breast cancer	8.7e-05	0.000433	CcSEcCtD
Moclobemide—Rash—Irinotecan—breast cancer	8.67e-05	0.000431	CcSEcCtD
Moclobemide—Rash—Mitoxantrone—breast cancer	8.67e-05	0.000431	CcSEcCtD
Moclobemide—Dermatitis—Irinotecan—breast cancer	8.66e-05	0.000431	CcSEcCtD
Moclobemide—Dermatitis—Mitoxantrone—breast cancer	8.66e-05	0.000431	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Docetaxel—breast cancer	8.66e-05	0.000431	CcSEcCtD
Moclobemide—Headache—Mitoxantrone—breast cancer	8.61e-05	0.000428	CcSEcCtD
Moclobemide—Headache—Irinotecan—breast cancer	8.61e-05	0.000428	CcSEcCtD
Moclobemide—Hypotension—Capecitabine—breast cancer	8.6e-05	0.000428	CcSEcCtD
Moclobemide—Insomnia—Docetaxel—breast cancer	8.6e-05	0.000428	CcSEcCtD
Moclobemide—Paraesthesia—Docetaxel—breast cancer	8.54e-05	0.000425	CcSEcCtD
Moclobemide—Vomiting—Gemcitabine—breast cancer	8.52e-05	0.000424	CcSEcCtD
Moclobemide—Bradycardia—Doxorubicin—breast cancer	8.5e-05	0.000423	CcSEcCtD
Moclobemide—Dyspnoea—Docetaxel—breast cancer	8.47e-05	0.000422	CcSEcCtD
Moclobemide—Somnolence—Docetaxel—breast cancer	8.45e-05	0.00042	CcSEcCtD
Moclobemide—Rash—Gemcitabine—breast cancer	8.45e-05	0.00042	CcSEcCtD
Moclobemide—Dermatitis—Gemcitabine—breast cancer	8.44e-05	0.00042	CcSEcCtD
Moclobemide—Tinnitus—Epirubicin—breast cancer	8.41e-05	0.000419	CcSEcCtD
Moclobemide—Headache—Gemcitabine—breast cancer	8.39e-05	0.000417	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Capecitabine—breast cancer	8.39e-05	0.000417	CcSEcCtD
Moclobemide—Flushing—Epirubicin—breast cancer	8.38e-05	0.000417	CcSEcCtD
Moclobemide—Vomiting—Fluorouracil—breast cancer	8.37e-05	0.000417	CcSEcCtD
Moclobemide—Dyspepsia—Docetaxel—breast cancer	8.37e-05	0.000416	CcSEcCtD
Moclobemide—Insomnia—Capecitabine—breast cancer	8.32e-05	0.000414	CcSEcCtD
Moclobemide—Rash—Fluorouracil—breast cancer	8.3e-05	0.000413	CcSEcCtD
Moclobemide—Dermatitis—Fluorouracil—breast cancer	8.3e-05	0.000413	CcSEcCtD
Moclobemide—Paraesthesia—Capecitabine—breast cancer	8.26e-05	0.000411	CcSEcCtD
Moclobemide—Decreased appetite—Docetaxel—breast cancer	8.26e-05	0.000411	CcSEcCtD
Moclobemide—Headache—Fluorouracil—breast cancer	8.25e-05	0.00041	CcSEcCtD
Moclobemide—Dysgeusia—Methotrexate—breast cancer	8.22e-05	0.000409	CcSEcCtD
Moclobemide—Dyspnoea—Capecitabine—breast cancer	8.21e-05	0.000408	CcSEcCtD
Moclobemide—Fatigue—Docetaxel—breast cancer	8.2e-05	0.000408	CcSEcCtD
Moclobemide—Nausea—Mitoxantrone—breast cancer	8.17e-05	0.000406	CcSEcCtD
Moclobemide—Nausea—Irinotecan—breast cancer	8.17e-05	0.000406	CcSEcCtD
Moclobemide—Constipation—Docetaxel—breast cancer	8.13e-05	0.000404	CcSEcCtD
Moclobemide—Dyspepsia—Capecitabine—breast cancer	8.1e-05	0.000403	CcSEcCtD
Moclobemide—Visual impairment—Doxorubicin—breast cancer	8.05e-05	0.0004	CcSEcCtD
Moclobemide—Asthenia—Paclitaxel—breast cancer	8.05e-05	0.0004	CcSEcCtD
Moclobemide—Decreased appetite—Capecitabine—breast cancer	8e-05	0.000398	CcSEcCtD
Moclobemide—Nausea—Gemcitabine—breast cancer	7.96e-05	0.000396	CcSEcCtD
Moclobemide—Fatigue—Capecitabine—breast cancer	7.93e-05	0.000395	CcSEcCtD
Moclobemide—Pruritus—Paclitaxel—breast cancer	7.93e-05	0.000395	CcSEcCtD
Moclobemide—Vision blurred—Methotrexate—breast cancer	7.91e-05	0.000394	CcSEcCtD
Moclobemide—Constipation—Capecitabine—breast cancer	7.87e-05	0.000391	CcSEcCtD
Moclobemide—Feeling abnormal—Docetaxel—breast cancer	7.83e-05	0.00039	CcSEcCtD
Moclobemide—Nausea—Fluorouracil—breast cancer	7.82e-05	0.000389	CcSEcCtD
Moclobemide—Ill-defined disorder—Methotrexate—breast cancer	7.79e-05	0.000387	CcSEcCtD
Moclobemide—Tinnitus—Doxorubicin—breast cancer	7.79e-05	0.000387	CcSEcCtD
Moclobemide—Gastrointestinal pain—Docetaxel—breast cancer	7.77e-05	0.000387	CcSEcCtD
Moclobemide—Flushing—Doxorubicin—breast cancer	7.75e-05	0.000385	CcSEcCtD
Moclobemide—Flatulence—Epirubicin—breast cancer	7.74e-05	0.000385	CcSEcCtD
Moclobemide—Tension—Epirubicin—breast cancer	7.71e-05	0.000383	CcSEcCtD
Moclobemide—Dysgeusia—Epirubicin—breast cancer	7.69e-05	0.000383	CcSEcCtD
Moclobemide—Diarrhoea—Paclitaxel—breast cancer	7.67e-05	0.000382	CcSEcCtD
Moclobemide—Nervousness—Epirubicin—breast cancer	7.63e-05	0.00038	CcSEcCtD
Moclobemide—Feeling abnormal—Capecitabine—breast cancer	7.58e-05	0.000377	CcSEcCtD
Moclobemide—Malaise—Methotrexate—breast cancer	7.57e-05	0.000377	CcSEcCtD
Moclobemide—Gastrointestinal pain—Capecitabine—breast cancer	7.53e-05	0.000374	CcSEcCtD
Moclobemide—Abdominal pain—Docetaxel—breast cancer	7.51e-05	0.000374	CcSEcCtD
Moclobemide—Dizziness—Paclitaxel—breast cancer	7.42e-05	0.000369	CcSEcCtD
Moclobemide—Vision blurred—Epirubicin—breast cancer	7.4e-05	0.000368	CcSEcCtD
Moclobemide—Urticaria—Capecitabine—breast cancer	7.31e-05	0.000364	CcSEcCtD
Moclobemide—Ill-defined disorder—Epirubicin—breast cancer	7.29e-05	0.000363	CcSEcCtD
Moclobemide—Abdominal pain—Capecitabine—breast cancer	7.28e-05	0.000362	CcSEcCtD
Moclobemide—Agitation—Epirubicin—breast cancer	7.22e-05	0.000359	CcSEcCtD
Moclobemide—Flatulence—Doxorubicin—breast cancer	7.16e-05	0.000356	CcSEcCtD
Moclobemide—Myalgia—Methotrexate—breast cancer	7.15e-05	0.000355	CcSEcCtD
Moclobemide—Chest pain—Methotrexate—breast cancer	7.15e-05	0.000355	CcSEcCtD
Moclobemide—Tension—Doxorubicin—breast cancer	7.13e-05	0.000355	CcSEcCtD
Moclobemide—Vomiting—Paclitaxel—breast cancer	7.13e-05	0.000355	CcSEcCtD
Moclobemide—Dysgeusia—Doxorubicin—breast cancer	7.12e-05	0.000354	CcSEcCtD
Moclobemide—Malaise—Epirubicin—breast cancer	7.08e-05	0.000352	CcSEcCtD
Moclobemide—Rash—Paclitaxel—breast cancer	7.07e-05	0.000352	CcSEcCtD
Moclobemide—Dermatitis—Paclitaxel—breast cancer	7.06e-05	0.000351	CcSEcCtD
Moclobemide—Discomfort—Methotrexate—breast cancer	7.06e-05	0.000351	CcSEcCtD
Moclobemide—Nervousness—Doxorubicin—breast cancer	7.06e-05	0.000351	CcSEcCtD
Moclobemide—Syncope—Epirubicin—breast cancer	7.05e-05	0.00035	CcSEcCtD
Moclobemide—Headache—Paclitaxel—breast cancer	7.03e-05	0.000349	CcSEcCtD
Moclobemide—Palpitations—Epirubicin—breast cancer	6.94e-05	0.000345	CcSEcCtD
Moclobemide—Confusional state—Methotrexate—breast cancer	6.91e-05	0.000344	CcSEcCtD
Moclobemide—Loss of consciousness—Epirubicin—breast cancer	6.91e-05	0.000343	CcSEcCtD
Moclobemide—Vision blurred—Doxorubicin—breast cancer	6.85e-05	0.000341	CcSEcCtD
Moclobemide—Asthenia—Docetaxel—breast cancer	6.82e-05	0.000339	CcSEcCtD
Moclobemide—Hypertension—Epirubicin—breast cancer	6.78e-05	0.000337	CcSEcCtD
Moclobemide—Ill-defined disorder—Doxorubicin—breast cancer	6.74e-05	0.000335	CcSEcCtD
Moclobemide—Pruritus—Docetaxel—breast cancer	6.73e-05	0.000335	CcSEcCtD
Moclobemide—Myalgia—Epirubicin—breast cancer	6.69e-05	0.000333	CcSEcCtD
Moclobemide—Chest pain—Epirubicin—breast cancer	6.69e-05	0.000333	CcSEcCtD
Moclobemide—Agitation—Doxorubicin—breast cancer	6.68e-05	0.000332	CcSEcCtD
Moclobemide—Anxiety—Epirubicin—breast cancer	6.67e-05	0.000332	CcSEcCtD
Moclobemide—Nausea—Paclitaxel—breast cancer	6.66e-05	0.000331	CcSEcCtD
Moclobemide—Hyperhidrosis—Methotrexate—breast cancer	6.62e-05	0.000329	CcSEcCtD
Moclobemide—Discomfort—Epirubicin—breast cancer	6.61e-05	0.000329	CcSEcCtD
Moclobemide—Asthenia—Capecitabine—breast cancer	6.6e-05	0.000328	CcSEcCtD
Moclobemide—Malaise—Doxorubicin—breast cancer	6.56e-05	0.000326	CcSEcCtD
Moclobemide—Dry mouth—Epirubicin—breast cancer	6.54e-05	0.000325	CcSEcCtD
Moclobemide—Syncope—Doxorubicin—breast cancer	6.52e-05	0.000324	CcSEcCtD
Moclobemide—Pruritus—Capecitabine—breast cancer	6.51e-05	0.000324	CcSEcCtD
Moclobemide—Diarrhoea—Docetaxel—breast cancer	6.5e-05	0.000324	CcSEcCtD
Moclobemide—Confusional state—Epirubicin—breast cancer	6.47e-05	0.000322	CcSEcCtD
Moclobemide—Palpitations—Doxorubicin—breast cancer	6.42e-05	0.00032	CcSEcCtD
Moclobemide—Hypotension—Methotrexate—breast cancer	6.4e-05	0.000318	CcSEcCtD
Moclobemide—Loss of consciousness—Doxorubicin—breast cancer	6.39e-05	0.000318	CcSEcCtD
Moclobemide—Shock—Epirubicin—breast cancer	6.31e-05	0.000314	CcSEcCtD
Moclobemide—Diarrhoea—Capecitabine—breast cancer	6.3e-05	0.000313	CcSEcCtD
Moclobemide—Dizziness—Docetaxel—breast cancer	6.29e-05	0.000313	CcSEcCtD
Moclobemide—Hypertension—Doxorubicin—breast cancer	6.28e-05	0.000312	CcSEcCtD
Moclobemide—Tachycardia—Epirubicin—breast cancer	6.26e-05	0.000311	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Methotrexate—breast cancer	6.24e-05	0.00031	CcSEcCtD
Moclobemide—Hyperhidrosis—Epirubicin—breast cancer	6.2e-05	0.000308	CcSEcCtD
Moclobemide—Insomnia—Methotrexate—breast cancer	6.2e-05	0.000308	CcSEcCtD
Moclobemide—Chest pain—Doxorubicin—breast cancer	6.19e-05	0.000308	CcSEcCtD
Moclobemide—Myalgia—Doxorubicin—breast cancer	6.19e-05	0.000308	CcSEcCtD
Moclobemide—Anxiety—Doxorubicin—breast cancer	6.17e-05	0.000307	CcSEcCtD
Moclobemide—Paraesthesia—Methotrexate—breast cancer	6.15e-05	0.000306	CcSEcCtD
Moclobemide—Discomfort—Doxorubicin—breast cancer	6.11e-05	0.000304	CcSEcCtD
Moclobemide—Dyspnoea—Methotrexate—breast cancer	6.11e-05	0.000304	CcSEcCtD
Moclobemide—Somnolence—Methotrexate—breast cancer	6.09e-05	0.000303	CcSEcCtD
Moclobemide—Dizziness—Capecitabine—breast cancer	6.09e-05	0.000303	CcSEcCtD
Moclobemide—Dry mouth—Doxorubicin—breast cancer	6.05e-05	0.000301	CcSEcCtD
Moclobemide—Vomiting—Docetaxel—breast cancer	6.04e-05	0.000301	CcSEcCtD
Moclobemide—Dyspepsia—Methotrexate—breast cancer	6.03e-05	0.0003	CcSEcCtD
Moclobemide—Rash—Docetaxel—breast cancer	5.99e-05	0.000298	CcSEcCtD
Moclobemide—Hypotension—Epirubicin—breast cancer	5.99e-05	0.000298	CcSEcCtD
Moclobemide—Dermatitis—Docetaxel—breast cancer	5.99e-05	0.000298	CcSEcCtD
Moclobemide—Confusional state—Doxorubicin—breast cancer	5.98e-05	0.000298	CcSEcCtD
Moclobemide—Decreased appetite—Methotrexate—breast cancer	5.96e-05	0.000296	CcSEcCtD
Moclobemide—Headache—Docetaxel—breast cancer	5.96e-05	0.000296	CcSEcCtD
Moclobemide—Fatigue—Methotrexate—breast cancer	5.91e-05	0.000294	CcSEcCtD
Moclobemide—Vomiting—Capecitabine—breast cancer	5.85e-05	0.000291	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Epirubicin—breast cancer	5.84e-05	0.000291	CcSEcCtD
Moclobemide—Shock—Doxorubicin—breast cancer	5.84e-05	0.00029	CcSEcCtD
Moclobemide—Rash—Capecitabine—breast cancer	5.8e-05	0.000289	CcSEcCtD
Moclobemide—Insomnia—Epirubicin—breast cancer	5.8e-05	0.000288	CcSEcCtD
Moclobemide—Dermatitis—Capecitabine—breast cancer	5.8e-05	0.000288	CcSEcCtD
Moclobemide—Tachycardia—Doxorubicin—breast cancer	5.79e-05	0.000288	CcSEcCtD
Moclobemide—Headache—Capecitabine—breast cancer	5.77e-05	0.000287	CcSEcCtD
Moclobemide—Paraesthesia—Epirubicin—breast cancer	5.76e-05	0.000286	CcSEcCtD
Moclobemide—Hyperhidrosis—Doxorubicin—breast cancer	5.74e-05	0.000285	CcSEcCtD
Moclobemide—Dyspnoea—Epirubicin—breast cancer	5.72e-05	0.000284	CcSEcCtD
Moclobemide—Somnolence—Epirubicin—breast cancer	5.7e-05	0.000284	CcSEcCtD
Moclobemide—Nausea—Docetaxel—breast cancer	5.65e-05	0.000281	CcSEcCtD
Moclobemide—Feeling abnormal—Methotrexate—breast cancer	5.65e-05	0.000281	CcSEcCtD
Moclobemide—Dyspepsia—Epirubicin—breast cancer	5.64e-05	0.000281	CcSEcCtD
Moclobemide—Gastrointestinal pain—Methotrexate—breast cancer	5.6e-05	0.000279	CcSEcCtD
Moclobemide—Decreased appetite—Epirubicin—breast cancer	5.57e-05	0.000277	CcSEcCtD
Moclobemide—Hypotension—Doxorubicin—breast cancer	5.54e-05	0.000276	CcSEcCtD
Moclobemide—Fatigue—Epirubicin—breast cancer	5.53e-05	0.000275	CcSEcCtD
Moclobemide—Constipation—Epirubicin—breast cancer	5.48e-05	0.000273	CcSEcCtD
Moclobemide—Nausea—Capecitabine—breast cancer	5.47e-05	0.000272	CcSEcCtD
Moclobemide—Urticaria—Methotrexate—breast cancer	5.44e-05	0.000271	CcSEcCtD
Moclobemide—Abdominal pain—Methotrexate—breast cancer	5.42e-05	0.000269	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Doxorubicin—breast cancer	5.41e-05	0.000269	CcSEcCtD
Moclobemide—Insomnia—Doxorubicin—breast cancer	5.37e-05	0.000267	CcSEcCtD
Moclobemide—Paraesthesia—Doxorubicin—breast cancer	5.33e-05	0.000265	CcSEcCtD
Moclobemide—Dyspnoea—Doxorubicin—breast cancer	5.29e-05	0.000263	CcSEcCtD
Moclobemide—Feeling abnormal—Epirubicin—breast cancer	5.28e-05	0.000263	CcSEcCtD
Moclobemide—Somnolence—Doxorubicin—breast cancer	5.27e-05	0.000262	CcSEcCtD
Moclobemide—Gastrointestinal pain—Epirubicin—breast cancer	5.24e-05	0.000261	CcSEcCtD
Moclobemide—Dyspepsia—Doxorubicin—breast cancer	5.22e-05	0.00026	CcSEcCtD
Moclobemide—Decreased appetite—Doxorubicin—breast cancer	5.16e-05	0.000257	CcSEcCtD
Moclobemide—Fatigue—Doxorubicin—breast cancer	5.11e-05	0.000254	CcSEcCtD
Moclobemide—Urticaria—Epirubicin—breast cancer	5.09e-05	0.000253	CcSEcCtD
Moclobemide—Constipation—Doxorubicin—breast cancer	5.07e-05	0.000252	CcSEcCtD
Moclobemide—Abdominal pain—Epirubicin—breast cancer	5.07e-05	0.000252	CcSEcCtD
Moclobemide—Asthenia—Methotrexate—breast cancer	4.92e-05	0.000245	CcSEcCtD
Moclobemide—Feeling abnormal—Doxorubicin—breast cancer	4.89e-05	0.000243	CcSEcCtD
Moclobemide—Gastrointestinal pain—Doxorubicin—breast cancer	4.85e-05	0.000241	CcSEcCtD
Moclobemide—Pruritus—Methotrexate—breast cancer	4.85e-05	0.000241	CcSEcCtD
Moclobemide—Urticaria—Doxorubicin—breast cancer	4.71e-05	0.000234	CcSEcCtD
Moclobemide—Abdominal pain—Doxorubicin—breast cancer	4.69e-05	0.000233	CcSEcCtD
Moclobemide—Diarrhoea—Methotrexate—breast cancer	4.69e-05	0.000233	CcSEcCtD
Moclobemide—Asthenia—Epirubicin—breast cancer	4.6e-05	0.000229	CcSEcCtD
Moclobemide—Pruritus—Epirubicin—breast cancer	4.54e-05	0.000226	CcSEcCtD
Moclobemide—Dizziness—Methotrexate—breast cancer	4.53e-05	0.000225	CcSEcCtD
Moclobemide—Diarrhoea—Epirubicin—breast cancer	4.39e-05	0.000218	CcSEcCtD
Moclobemide—Vomiting—Methotrexate—breast cancer	4.36e-05	0.000217	CcSEcCtD
Moclobemide—Rash—Methotrexate—breast cancer	4.32e-05	0.000215	CcSEcCtD
Moclobemide—Dermatitis—Methotrexate—breast cancer	4.32e-05	0.000215	CcSEcCtD
Moclobemide—Headache—Methotrexate—breast cancer	4.29e-05	0.000213	CcSEcCtD
Moclobemide—Asthenia—Doxorubicin—breast cancer	4.26e-05	0.000212	CcSEcCtD
Moclobemide—Dizziness—Epirubicin—breast cancer	4.24e-05	0.000211	CcSEcCtD
Moclobemide—Pruritus—Doxorubicin—breast cancer	4.2e-05	0.000209	CcSEcCtD
Moclobemide—Vomiting—Epirubicin—breast cancer	4.08e-05	0.000203	CcSEcCtD
Moclobemide—Nausea—Methotrexate—breast cancer	4.07e-05	0.000202	CcSEcCtD
Moclobemide—Diarrhoea—Doxorubicin—breast cancer	4.06e-05	0.000202	CcSEcCtD
Moclobemide—Rash—Epirubicin—breast cancer	4.04e-05	0.000201	CcSEcCtD
Moclobemide—Dermatitis—Epirubicin—breast cancer	4.04e-05	0.000201	CcSEcCtD
Moclobemide—Headache—Epirubicin—breast cancer	4.02e-05	0.0002	CcSEcCtD
Moclobemide—Dizziness—Doxorubicin—breast cancer	3.92e-05	0.000195	CcSEcCtD
Moclobemide—Nausea—Epirubicin—breast cancer	3.81e-05	0.000189	CcSEcCtD
Moclobemide—Vomiting—Doxorubicin—breast cancer	3.77e-05	0.000188	CcSEcCtD
Moclobemide—Rash—Doxorubicin—breast cancer	3.74e-05	0.000186	CcSEcCtD
Moclobemide—Dermatitis—Doxorubicin—breast cancer	3.74e-05	0.000186	CcSEcCtD
Moclobemide—Headache—Doxorubicin—breast cancer	3.72e-05	0.000185	CcSEcCtD
Moclobemide—Nausea—Doxorubicin—breast cancer	3.52e-05	0.000175	CcSEcCtD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	9.85e-06	9.77e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	9.85e-06	9.77e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ALDOA—breast cancer	9.84e-06	9.76e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CAV1—breast cancer	9.69e-06	9.62e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CA9—breast cancer	9.55e-06	9.47e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTA4—breast cancer	9.55e-06	9.47e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—NCOA3—breast cancer	9.55e-06	9.47e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—SLC2A2—breast cancer	9.48e-06	9.41e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—breast cancer	9.43e-06	9.35e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—breast cancer	9.39e-06	9.32e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	9.39e-06	9.31e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	9.34e-06	9.26e-05	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PTEN—breast cancer	9.32e-06	9.24e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTA2—breast cancer	9.31e-06	9.23e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GPX2—breast cancer	9.31e-06	9.23e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ABCG2—breast cancer	9.29e-06	9.22e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CPT1A—breast cancer	9.29e-06	9.22e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—MTR—breast cancer	9.29e-06	9.22e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GPX4—breast cancer	9.19e-06	9.12e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SULT1A1—breast cancer	9.19e-06	9.12e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—MED12—breast cancer	9.19e-06	9.12e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—DPYD—breast cancer	9.19e-06	9.12e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—DPYD—breast cancer	9.11e-06	9.04e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—MED12—breast cancer	9.11e-06	9.04e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—HPGDS—breast cancer	9.11e-06	9.04e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—HBA1—breast cancer	9.05e-06	8.98e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ALDOA—breast cancer	9.05e-06	8.98e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTA1—breast cancer	8.98e-06	8.91e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—IDH1—breast cancer	8.98e-06	8.91e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ALDOA—breast cancer	8.97e-06	8.9e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NAT2—breast cancer	8.88e-06	8.81e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ACHE—breast cancer	8.84e-06	8.77e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GSTT1—breast cancer	8.84e-06	8.77e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PIK3CG—breast cancer	8.83e-06	8.76e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—NCOA3—breast cancer	8.78e-06	8.71e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SLC2A2—breast cancer	8.72e-06	8.65e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—NCOA3—breast cancer	8.71e-06	8.64e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SLC2A2—breast cancer	8.65e-06	8.58e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	8.56e-06	8.49e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ABCG2—breast cancer	8.55e-06	8.48e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CPT1A—breast cancer	8.55e-06	8.48e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—MTR—breast cancer	8.55e-06	8.48e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CPT1A—breast cancer	8.47e-06	8.4e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—MTR—breast cancer	8.47e-06	8.4e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ABCG2—breast cancer	8.47e-06	8.4e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—HPGDS—breast cancer	8.38e-06	8.31e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP17A1—breast cancer	8.37e-06	8.3e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—HBA1—breast cancer	8.33e-06	8.26e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—HPGDS—breast cancer	8.31e-06	8.24e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PTGS1—breast cancer	8.28e-06	8.21e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ENO1—breast cancer	8.28e-06	8.21e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—HBA1—breast cancer	8.26e-06	8.19e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	8.25e-06	8.18e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—breast cancer	8.14e-06	8.08e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GSTT1—breast cancer	8.13e-06	8.06e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ACHE—breast cancer	8.13e-06	8.06e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP2D6—breast cancer	8.12e-06	8.06e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GSTT1—breast cancer	8.06e-06	7.99e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ACHE—breast cancer	8.06e-06	7.99e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	8.03e-06	7.96e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—NCOA2—breast cancer	7.97e-06	7.91e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—DPYD—breast cancer	7.79e-06	7.72e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—MED12—breast cancer	7.79e-06	7.72e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PIK3CD—breast cancer	7.76e-06	7.7e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—FASN—breast cancer	7.73e-06	7.67e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—BCHE—breast cancer	7.7e-06	7.64e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP17A1—breast cancer	7.69e-06	7.63e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ALDOA—breast cancer	7.67e-06	7.6e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ALB—breast cancer	7.66e-06	7.6e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP17A1—breast cancer	7.63e-06	7.57e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ENO1—breast cancer	7.62e-06	7.55e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PTGS1—breast cancer	7.62e-06	7.55e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—SLC5A5—breast cancer	7.6e-06	7.54e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ENO1—breast cancer	7.55e-06	7.49e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PTGS1—breast cancer	7.55e-06	7.49e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	7.52e-06	7.46e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NCOA3—breast cancer	7.44e-06	7.38e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	7.43e-06	7.37e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP2D6—breast cancer	7.4e-06	7.34e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SLC2A2—breast cancer	7.39e-06	7.33e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—NQO1—breast cancer	7.34e-06	7.28e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—SLC2A1—breast cancer	7.34e-06	7.28e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—NCOA2—breast cancer	7.33e-06	7.27e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—NOS3—breast cancer	7.33e-06	7.27e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	7.31e-06	7.25e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—NCOA2—breast cancer	7.27e-06	7.21e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CPT1A—breast cancer	7.24e-06	7.18e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ABCG2—breast cancer	7.24e-06	7.18e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—MTR—breast cancer	7.24e-06	7.18e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	7.19e-06	7.13e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP3A4—breast cancer	7.16e-06	7.1e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	7.13e-06	7.07e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—FASN—breast cancer	7.11e-06	7.05e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—HPGDS—breast cancer	7.1e-06	7.04e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—BCHE—breast cancer	7.08e-06	7.02e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—HBA1—breast cancer	7.05e-06	7e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—FASN—breast cancer	7.05e-06	6.99e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP1B1—breast cancer	7.04e-06	6.98e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—BCHE—breast cancer	7.02e-06	6.96e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SLC5A5—breast cancer	6.99e-06	6.94e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SLC5A5—breast cancer	6.93e-06	6.88e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—HSP90AA1—breast cancer	6.91e-06	6.85e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTT1—breast cancer	6.89e-06	6.83e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ACHE—breast cancer	6.89e-06	6.83e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PIK3CB—breast cancer	6.77e-06	6.71e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SLC2A1—breast cancer	6.75e-06	6.7e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—NQO1—breast cancer	6.75e-06	6.7e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—NCOA1—breast cancer	6.72e-06	6.66e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PTGS2—breast cancer	6.7e-06	6.65e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SLC2A1—breast cancer	6.7e-06	6.64e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—NQO1—breast cancer	6.7e-06	6.64e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—STK11—breast cancer	6.62e-06	6.57e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP19A1—breast cancer	6.62e-06	6.57e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP3A4—breast cancer	6.59e-06	6.53e-05	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PIK3CA—breast cancer	6.57e-06	6.52e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	6.56e-06	6.5e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP3A4—breast cancer	6.53e-06	6.48e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP17A1—breast cancer	6.52e-06	6.47e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	6.5e-06	6.44e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP1B1—breast cancer	6.48e-06	6.42e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PTGS1—breast cancer	6.45e-06	6.4e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ENO1—breast cancer	6.45e-06	6.4e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	6.43e-06	6.38e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP1B1—breast cancer	6.42e-06	6.37e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—HSP90AA1—breast cancer	6.35e-06	6.3e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	6.35e-06	6.29e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP2D6—breast cancer	6.33e-06	6.28e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—HSP90AA1—breast cancer	6.3e-06	6.25e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	6.21e-06	6.16e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NCOA2—breast cancer	6.21e-06	6.16e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—NCOA1—breast cancer	6.18e-06	6.13e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—COMT—breast cancer	6.15e-06	6.1e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GSTP1—breast cancer	6.13e-06	6.08e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—NCOA1—breast cancer	6.12e-06	6.08e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—STK11—breast cancer	6.09e-06	6.04e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP19A1—breast cancer	6.09e-06	6.04e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—HMOX1—breast cancer	6.04e-06	5.99e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—STK11—breast cancer	6.04e-06	5.99e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP19A1—breast cancer	6.04e-06	5.99e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ITPR1—breast cancer	6.03e-06	5.98e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—FASN—breast cancer	6.02e-06	5.97e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—BCHE—breast cancer	6e-06	5.95e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SLC5A5—breast cancer	5.93e-06	5.88e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PTEN—breast cancer	5.85e-06	5.8e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ABCB1—breast cancer	5.8e-06	5.75e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NQO1—breast cancer	5.72e-06	5.68e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SLC2A1—breast cancer	5.72e-06	5.68e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—TYMS—breast cancer	5.69e-06	5.65e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	5.67e-06	5.62e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—COMT—breast cancer	5.66e-06	5.61e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GSTP1—breast cancer	5.63e-06	5.59e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—NCOR1—breast cancer	5.63e-06	5.58e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PLA2G4A—breast cancer	5.63e-06	5.58e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GSTM1—breast cancer	5.63e-06	5.58e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—COMT—breast cancer	5.61e-06	5.57e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	5.6e-06	5.56e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GSTP1—breast cancer	5.59e-06	5.54e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP3A4—breast cancer	5.58e-06	5.54e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—HMOX1—breast cancer	5.56e-06	5.51e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	5.55e-06	5.51e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ITPR1—breast cancer	5.54e-06	5.5e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—HMOX1—breast cancer	5.51e-06	5.46e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ITPR1—breast cancer	5.5e-06	5.45e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP1B1—breast cancer	5.49e-06	5.44e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GPX1—breast cancer	5.39e-06	5.35e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—HSP90AA1—breast cancer	5.38e-06	5.34e-05	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—AKT1—breast cancer	5.37e-06	5.33e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP1A1—breast cancer	5.34e-06	5.29e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ABCB1—breast cancer	5.33e-06	5.29e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ERCC2—breast cancer	5.29e-06	5.25e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ABCB1—breast cancer	5.29e-06	5.24e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—TYMS—breast cancer	5.24e-06	5.2e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NCOA1—breast cancer	5.23e-06	5.19e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—TYMS—breast cancer	5.19e-06	5.15e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—NCOR1—breast cancer	5.18e-06	5.14e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PLA2G4A—breast cancer	5.18e-06	5.14e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GSTM1—breast cancer	5.18e-06	5.14e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—STK11—breast cancer	5.16e-06	5.12e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP19A1—breast cancer	5.16e-06	5.12e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—NCOR1—breast cancer	5.13e-06	5.09e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PLA2G4A—breast cancer	5.13e-06	5.09e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GSTM1—breast cancer	5.13e-06	5.09e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—MTHFR—breast cancer	4.97e-06	4.93e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GPX1—breast cancer	4.96e-06	4.92e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GPX1—breast cancer	4.92e-06	4.88e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP1A1—breast cancer	4.91e-06	4.87e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ERCC2—breast cancer	4.87e-06	4.83e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP1A1—breast cancer	4.87e-06	4.83e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.84e-06	4.8e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ERCC2—breast cancer	4.83e-06	4.79e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—COMT—breast cancer	4.8e-06	4.76e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTP1—breast cancer	4.77e-06	4.73e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—HMOX1—breast cancer	4.71e-06	4.67e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ITPR1—breast cancer	4.7e-06	4.66e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CAV1—breast cancer	4.59e-06	4.55e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—MTHFR—breast cancer	4.58e-06	4.54e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—MTHFR—breast cancer	4.54e-06	4.5e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ABCB1—breast cancer	4.52e-06	4.48e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—TYMS—breast cancer	4.44e-06	4.4e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NCOR1—breast cancer	4.39e-06	4.35e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PLA2G4A—breast cancer	4.39e-06	4.35e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTM1—breast cancer	4.39e-06	4.35e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.38e-06	4.35e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CAV1—breast cancer	4.22e-06	4.19e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GPX1—breast cancer	4.2e-06	4.17e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CAV1—breast cancer	4.18e-06	4.15e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PIK3CG—breast cancer	4.18e-06	4.15e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP1A1—breast cancer	4.16e-06	4.12e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PIK3CA—breast cancer	4.12e-06	4.09e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ERCC2—breast cancer	4.12e-06	4.09e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4e-06	3.96e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—MTHFR—breast cancer	3.88e-06	3.84e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PIK3CG—breast cancer	3.84e-06	3.81e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PIK3CG—breast cancer	3.81e-06	3.78e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PIK3CD—breast cancer	3.67e-06	3.64e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ALB—breast cancer	3.63e-06	3.6e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CAV1—breast cancer	3.58e-06	3.55e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—NOS3—breast cancer	3.47e-06	3.44e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.42e-06	3.39e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PIK3CD—breast cancer	3.38e-06	3.35e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—AKT1—breast cancer	3.37e-06	3.34e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PIK3CD—breast cancer	3.35e-06	3.32e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ALB—breast cancer	3.34e-06	3.31e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ALB—breast cancer	3.31e-06	3.28e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PIK3CG—breast cancer	3.26e-06	3.23e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PIK3CB—breast cancer	3.2e-06	3.18e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—NOS3—breast cancer	3.19e-06	3.17e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PTGS2—breast cancer	3.17e-06	3.15e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—NOS3—breast cancer	3.16e-06	3.14e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PIK3CB—breast cancer	2.95e-06	2.92e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PIK3CB—breast cancer	2.92e-06	2.9e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PTGS2—breast cancer	2.92e-06	2.9e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PTGS2—breast cancer	2.89e-06	2.87e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PIK3CD—breast cancer	2.86e-06	2.84e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ALB—breast cancer	2.83e-06	2.8e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PTEN—breast cancer	2.77e-06	2.75e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NOS3—breast cancer	2.7e-06	2.68e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PTEN—breast cancer	2.55e-06	2.52e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PTEN—breast cancer	2.52e-06	2.5e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PIK3CB—breast cancer	2.5e-06	2.48e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PTGS2—breast cancer	2.47e-06	2.45e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PTEN—breast cancer	2.16e-06	2.14e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PIK3CA—breast cancer	1.95e-06	1.94e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PIK3CA—breast cancer	1.8e-06	1.78e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PIK3CA—breast cancer	1.78e-06	1.77e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—AKT1—breast cancer	1.59e-06	1.58e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PIK3CA—breast cancer	1.52e-06	1.51e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—AKT1—breast cancer	1.47e-06	1.46e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—AKT1—breast cancer	1.45e-06	1.44e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—AKT1—breast cancer	1.24e-06	1.23e-05	CbGpPWpGaD
